Captrust Financial Advisors Buys Shares of 12,629 Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)
Captrust Financial Advisors purchased a new position in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund purchased 12,629 shares of the company’s stock, valued at approximately $403,000. Several other hedge funds have also made changes to their positions in APLS. Teacher Retirement System of Texas […]
